A Phase II trial of cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagus
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 10 (3) , 170-172
- https://doi.org/10.1016/s0936-6555(98)80060-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagusCancer Chemotherapy and Pharmacology, 1996
- A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagusClinical Oncology, 1994
- Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junctionThe Annals of Thoracic Surgery, 1994
- Non-operative therapy of esophageal cancerDiseases of the Esophagus, 1994
- Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junctionGastroenterology, 1993
- Esophageal cancer: Does preoperative chemotherapy make a difference?Journal of Surgical Oncology, 1992
- A phase II study of 5-fluorouracil, adriamycin and mitomycin-C in adenocarcinoma of the oesophagusClinical Oncology, 1991
- A phase II study of carboplatin in adenocarcinoma of the oesophagusBritish Journal of Cancer, 1988
- Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagusThe Annals of Thoracic Surgery, 1988
- Reporting results of cancer treatmentCancer, 1981